Abstract
Reported attack rates from different batches of icterogenic serum-containing material administered parenterally vary considerably one from another, as shown in Table 1. These data were selected because they represent essentially complete follow-up studies on all known individuals receiving units of icterogenic substances from the common lots indicated. Specificity of Attack Rates Are the above differences in attack rates due more to volume of icterogenic material administered than to concentration of virus particles (assuming no difference in the qualitative capacity of a viable virus particle to infect), or is there a wide variation in the natural or acquired immunity (or both) in an otherwise fairly homogeneous healthy population? The only existing body of data large enough to be usefully applied to these questions is contained in the carefully prepared follow-up studies of Sawyer et al. (1944) on the outbreaks of serum hepatitis following the administration of 2 batches of the serum-containing
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.